Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation

BACKGROUND: Clozapine formulation has been shown to affect plasma concentrations of clozapine and norclozapine. Changes in formulation might result in toxicity or treatment failure. METHODS: We identified, from electronic records, patients who switched from clozapine tablets to oral liquid or vice v...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshavarzi, Farinaz, Fox, Tony, Whiskey, Eromona, Taylor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958650/
https://www.ncbi.nlm.nih.gov/pubmed/31976069
http://dx.doi.org/10.1177/2045125319899263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958650/
https://www.ncbi.nlm.nih.gov/pubmed/31976069
http://dx.doi.org/10.1177/2045125319899263

Ejemplares similares